DEF 14A: Westlake Chemical Partners LP Seeks Unitholder Approval for Incentive Plan Extension and Auditor Ratification

Sentiment:

Proxy Statement


Westlake Chemical Partners LP is holding a special meeting on May 8, 2024, to seek unitholder approval for extending its Long-Term Incentive Plan and ratifying the appointment of PricewaterhouseCoopers LLP as its independent auditor.

Summary

  • Westlake Chemical Partners LP is soliciting proxies for a special meeting of unitholders to be held on May 8, 2024.
  • The primary purposes of the meeting are to amend and restate the Partnership's Long-Term Incentive Plan and to ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024.
  • The Board of Directors unanimously recommends voting FOR both proposals.
  • The record date for determining unitholders entitled to vote at the special meeting was March 12, 2024.
  • As of the record date, there were 35,228,134 common units outstanding.
  • The Long-Term Incentive Plan, adopted on July 15, 2014, is set to terminate on July 15, 2024, unless extended.
  • The proposed amendment extends the plan for ten years from the date of unitholder approval.
  • No more than 1,270,000 common units may be delivered pursuant to awards under the existing Incentive Plan.
  • As of March 12, 2024, there were 1,198,853 common units available for future grant under the Incentive Plan.
  • As of March 12, 2024, 71,147 common units have been issued under the existing Incentive Plan, representing approximately 0.2% of outstanding common units.
  • WPT LLC, a wholly-owned subsidiary of Westlake, owns approximately 40.1% of the outstanding limited partner units and intends to vote in favor of both proposals.
  • The Partnership has retained Georgeson LLC to help solicit proxies for a fee of $15,000 plus expenses.
  • The Partnership has engaged Broadridge Financial Solutions, Inc. to tabulate voting results.

Sentiment

Score: 7

Explanation: The document is a standard proxy statement, presenting information in a neutral and factual manner. The recommendations are aligned with management's interests, and the overall tone is professional and informative.

Positives

  • The Board of Directors unanimously recommends voting FOR the approval of the amendment and restatement of the Incentive Plan.
  • The Board of Directors unanimously recommends voting FOR the ratification of the appointment of PricewaterhouseCoopers LLP to serve as the independent registered public accounting firm for the fiscal year ending December 31, 2024.
  • The proposed amendment extends the plan for ten years from the date of unitholder approval and does not increase the number of common units that may be delivered or reserved for delivery pursuant to awards.
  • WPT LLC, a wholly-owned subsidiary of Westlake, owns approximately 40.1% of the outstanding limited partner units and intends to vote in favor of both proposals.

Negatives

  • If unitholders do not approve the extension of the Long-Term Incentive Plan, the Partnership would no longer be able to grant equity-based awards after July 15, 2024.

Risks

  • The executive officers of the general partner also serve as directors or officers of Westlake and its affiliates, which may create conflicts of interest.
  • The Partnership is managed and operated by the Board of Directors and executive officers of the general partner, Westlake Chemical Partners GP LLC, a wholly-owned subsidiary of Westlake, and unitholders are not entitled to elect the general partner or its directors or otherwise directly participate in management or operations.

Future Outlook

The document seeks to extend the Long-Term Incentive Plan for another ten years, indicating a continued focus on incentivizing key personnel.

Management Comments

  • The Board of Directors unanimously recommends a vote FOR the approval of the amendment and restatement of the Incentive Plan.
  • The Board of Directors unanimously recommends a vote FOR the ratification of the appointment of PricewaterhouseCoopers LLP to serve as our independent registered public accounting firm for the fiscal year ending December 31, 2024.

Industry Context

The document reflects standard corporate governance practices, including seeking unitholder approval for significant matters like incentive plan extensions and auditor ratification.

Comparison to Industry Standards

  • The proxy statement follows standard SEC guidelines for disclosing information relevant to unitholder voting decisions.
  • The compensation discussion and analysis references peer groups and market surveys, which is a common practice in determining executive compensation.
  • The document discloses the fees paid to the independent auditor, which is a standard practice to ensure transparency and independence.

Stakeholder Impact

  • Approval of the incentive plan extension could positively impact employees and directors through continued equity-based compensation.
  • Ratification of the auditor appointment ensures continued independent oversight of the company's financial statements, benefiting shareholders.

Next Steps

  • Unitholders are requested to vote on the proposals either by the Internet, telephone, or by returning the proxy card.
  • The special meeting will be held on May 8, 2024, to vote on the proposals.

Key Dates

DateDescription
August 4, 2014Date of First Amended and Restated Agreement of Limited Partnership.
July 15, 2014Date the Long-Term Incentive Plan was adopted.
March 12, 2024Record date for determining unitholders entitled to vote at the special meeting.
March 18, 2024Date proxy materials were mailed to unitholders.
May 7, 2024Deadline for submitting or revoking proxies via the Internet, telephone, or mail.
May 8, 2024Date of the special meeting of unitholders.
July 15, 2024Date the Long-Term Incentive Plan will terminate if not extended.
December 31, 2024Fiscal year end for which PricewaterhouseCoopers LLP is being considered as the independent registered public accounting firm.

Keywords

proxy statement, incentive plan, unitholders, Westlake Chemical Partners LP, PricewaterhouseCoopers, ratification, amendment, common units, voting, awards

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.